Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

N/AActive Not RecruitingNCT06584630

Aristotle University Of Thessaloniki80 enrolled

Overview

Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Endometrial Cancer

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histological confirmation of endometrial cancer. * Surgical treatment at our Gynecological - Oncology Unit. Exclusion Criteria: * Refusal to be tested for the molecular classification * Presence of a synchronous neoplasm.

Locations (1)

1st Department of Obstetrics & Gynecology, AUTh, "Papageorgiou" Hospital

Thessaloniki, Greece

Outcomes

Primary Outcomes

Multidisciplinary Team Board decision change

MDT decision for adjuvant treatment (Rate of adjuvant treatment change)

Time frame: 2 years (study completion)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.